Chronic–Progressive Dopaminergic Deficiency Does Not Induce Midbrain Neurogenesis

Autor: Sigrid C. Schwarz, Mareike Fauser, Johannes Schwarz, Francisco Pan-Montojo, Andreas Hermann, Philipp J. Kahle, Christian Richter, Alexander Storch
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
Dopamine
Neurogenesis
adult neurogenesis
periventricular regions
non-neurogenic regions
Parkinson´s disease
dopaminergic neurodegeneration
transgenic animal model
Hindbrain
Biology
Receptors
Nicotinic

physiology [Mesencephalon]
Article
Midbrain
03 medical and health sciences
Lateral ventricles
deficiency [Dopamine]
0302 clinical medicine
Mesencephalon
Dopaminergic Cell
Lateral Ventricles
ddc:570
medicine
Animals
Humans
metabolism [alpha-Synuclein]
lcsh:QH301-705.5
Cell Proliferation
physiology [Lateral Ventricles]
Dopaminergic
Neurodegeneration
General Medicine
medicine.disease
Neural stem cell
Rhombencephalon
Mice
Inbred C57BL

030104 developmental biology
nervous system
lcsh:Biology (General)
metabolism [Receptors
Nicotinic]

physiology [Rhombencephalon]
alpha-Synuclein
Neuroscience
030217 neurology & neurosurgery
Zdroj: Cells, Vol 10, Iss 775, p 775 (2021)
Cells 10(4), 775-(2021). doi:10.3390/cells10040775
Cells
Volume 10
Issue 4
ISSN: 2073-4409
DOI: 10.3390/cells10040775
Popis: Background: Consecutive adult neurogenesis is a well-known phenomenon in the ventricular–subventricular zone of the lateral wall of the lateral ventricles (V–SVZ) and has been controversially discussed in so-called “non-neurogenic” brain areas such as the periventricular regions (PVRs) of the aqueduct and the fourth ventricle. Dopamine is a known modulator of adult neural stem cell (aNSC) proliferation and dopaminergic neurogenesis in the olfactory bulb, though a possible interplay between local dopaminergic neurodegeneration and induction of aNSC proliferation in mid/hindbrain PVRs is currently enigmatic. Objective/Hypothesis: To analyze the influence of chronic–progressive dopaminergic neurodegeneration on both consecutive adult neurogenesis in the PVRs of the V–SVZ and mid/hindbrain aNSCs in two mechanistically different transgenic animal models of Parkinson´s disease (PD). Methods: We used Thy1-m[A30P]h α synuclein mice and Leu9′Ser hypersensitive α4* nAChR mice to assess the influence of midbrain dopaminergic neuronal loss on neurogenic activity in the PVRs of the V–SVZ, the aqueduct and the fourth ventricle. Results: In both animal models, overall proliferative activity in the V–SVZ was not altered, though the proportion of B2/activated B1 cells on all proliferating cells was reduced in the V–SVZ in Leu9′Ser hypersensitive α4* nAChR mice. Putative aNSCs in the mid/hindbrain PVRs are known to be quiescent in vivo in healthy controls, and dopaminergic deficiency did not induce proliferative activity in these regions in both disease models. Conclusions: Our data do not support an activation of endogenous aNSCs in mid/hindbrain PVRs after local dopaminergic neurodegeneration. Spontaneous endogenous regeneration of dopaminergic cell loss through resident aNSCs is therefore unlikely.
Databáze: OpenAIRE